US2002007069A1PendingUtilityA1
Process of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl] sulfinyl-1 H-benzimidazole
Priority: Jul 13, 1998Filed: Jul 30, 2001Published: Jan 17, 2002
Est. expiryJul 13, 2018(expired)· nominal 20-yr term from priority
C07D 401/12A61P 1/04C07B 41/06A61P 1/00
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An improved process of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1 H-benzimidazole (omeprazole) by oxidation of 5-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole with 3-chloroperoxybenzoic acid in ethyl acetate wherein omeprazole is poorly soluble, at a temperature between −10° C. and 5° C. is disclosed. The second step is a purification of the crude product by dissolution and reprecipitation of the final product.
Claims
exact text as granted — not AI-modified1 . Process for preparing 5-methoxy-2-[(4-methoxy-3,5-dinethyl-2-pyridyl)methyl]sulfinyl-1H-benzimidazole (omeprazole) of the formula
characterized in that 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole is reacted with 3-chloroperoxybenzoic acid in ethyl acetate at a temperature between −10° C. and 5° C. and the product formed is purified by dissolution in an aqueous solution of methylamine, by precipitation under addition of hydrochloric acid and isolation of the title compound in a pure form.Join the waitlist — get patent alerts
Track US2002007069A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.